A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects
Clinical trial NCT02429102 · COMPLETED
Trial details
- NCT number
- NCT02429102
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.